Zebrafish embryos help prove what happens to nanoparticles in the blood

A variety of nanoparticles are designed for targeted drug delivery, but unfortunately only a very small proportion of the injected nanoparticles reach the target site such as solid tumors. The reason behind the low targeting efficiency is often considered a "black box" and had thus been little explored for many years.